Please sign in to follow a disease.
Hepatitis
MONDO:0002251An active inflammatory process affecting the liver for more than six months. Causes include viral infections, autoimmune disorders, drugs, and metabolic disorders.
Also known as: Hepatitis, hepatitis, inflammation of liver, liver inflammation, acute and subacute liver necrosis, acute hepatitis, acute/subac. necrosis of liver, animal hepatitis
734 clinical trials for this condition and its sub-types, 51 tagged with Hepatitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hepatitis
-
Viral hepatitis 12 trials · 443 incl. sub-types
6 sub-types
- Hepatitis B virus infection 251 trials · 274 incl. sub-types Sub-types →
- Hepatitis C virus infection 158 trials · 162 incl. sub-types Sub-types →
- Hepatitis D virus infection 47 trials
- Hepatitis A virus infection 10 trials
- Hepatitis E virus infection 5 trials
- Epstein-Barr virus hepatitis 0 trials
-
Alcoholic hepatitis 32 trials
-
Autoimmune hepatitis 30 trials · 31 incl. sub-types
7 sub-types
- Autoimmune cholangitis 1 trial
- Autoimmune hepatitis type 1 0 trials
- Autoimmune hepatitis type 2 0 trials
- Autoimmune hepatitis type 3 0 trials
- Giant cell hepatitis with autoimmune hemolytic anemia 0 trials
- Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome 0 trials
- Seronegative autoimmune hepatitis 0 trials
-
Drug-induced hepatitis 3 trials
-
Fulminant viral hepatitis 3 trials
-
Granulomatous hepatitis 0 trials
-
Hepatic tuberculosis 0 trials
-
Idiopathic peliosis hepatis 0 trials
Most studied deeper sub-types
-
Can a targeted antibody stop severe hepatitis from destroying Children's livers?
Disease control Not yet recruitingThis trial tests whether a medicine called emapalumab, which calms a specific part of the immune system, can prevent liver failure in children aged 1 year and older with severe hepatitis that hasn't improved with steroids. The study includes a screening group to observe all sever…
Phase 2 • Sponsor: Children's Healthcare of Atlanta • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New drug aims to melt liver fat and stop scarring in MASH patients
Disease control Not yet recruitingThis study tests an experimental drug called ALN-CIDEB in 150 adults with MASH, a serious liver disease involving fat buildup and scarring. The goal is to see if the drug can reduce liver fat, injury, and scarring compared to a placebo. Participants will receive either the drug o…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for immunotherapy side effects: blood filtering may replace steroids
Disease control Not yet recruitingThis study tests a treatment called extracorporeal photopheresis (ECP) for people with advanced melanoma who develop severe colitis or hepatitis from immunotherapy. ECP filters a patient's blood, treats it with a light-activated drug, and returns it to the body. The trial compare…
Phase 2 • Sponsor: Therakos LLC • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can your local pharmacy help stop HIV and STIs? new study aims to find out.
Prevention Not yet recruitingThis study will test whether offering HIV prevention medication, routine STI testing, and a preventive antibiotic at retail pharmacies helps young women avoid infections. About 720 women aged 15 to 24 who visit pharmacies for birth control will take part. Researchers will check h…
Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
New program aims to help ugandan men open up about HIV
Knowledge-focused Not yet recruitingThis study is testing a new program to help men living with HIV in Uganda feel more comfortable telling their sexual partners about their HIV status. The program includes education, counseling, and practice conversations. Researchers want to see if it helps more men share their s…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
New blood test may predict infection risk after liver transplant
Knowledge-focused Not yet recruitingThis study aims to create a score that predicts the risk of infection within 30 days after a liver transplant. Researchers will collect blood samples from 279 liver transplant patients before and after surgery to measure immune markers. The goal is to combine these markers with o…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Massive french study to track virus effects on pregnant women and kids for 7 years
Knowledge-focused Not yet recruitingThis study will follow 5,160 pregnant women in France who have HIV, hepatitis B, hepatitis C, or an arbovirus infection (like Zika or dengue), along with their children, for up to 7 years. Researchers want to learn how these viruses and their treatments affect pregnancy, the moth…
Sponsor: ANRS, Emerging Infectious Diseases • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC